Lorazepam Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Lorazepam Injection (injection) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on 09/05/2018. Reported reason: Other
Shortage Details
- Status
- Current
- Company
- Hikma Pharmaceuticals USA, Inc.
- Package NDC
- 0641-6046-10
- Dosage Form
- Injection
- Presentation
- Lorazepam, Injection, 2 mg/1 mL (NDC 0641-6046-10)
- Initial Posting
- 09/05/2018
- Revised Date
Reason
Other